Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03075527
Brief Title: A Phase 2 Study of Durvalumab in Combination With Tremelimumab in Malignant Pleural Mesothelioma

First Submitted : March 2, 2017
First Submitted that Met QC Criteria : March 6, 2017
First Posted : March 9, 2017

Results First Submitted : August 23, 2019
Results First Submitted that Met QC Criteria : October 21, 2019
Results First Posted : November 12, 2019

Last Update Submitted that Met QC Criteria : March 30, 2021
Last Update Posted : April 1, 2021